29 results
8-K
EX-1.1
PROK
ProKidney Corp - Ordinary Shares
13 Jun 24
ProKidney Announces Pricing of its Upsized $130 Million Public Offering of Class A Ordinary Shares and Concurrent Registered Direct Offering
9:06am
accounting firm as required by the Securities Act, the Exchange Act, and the rules of the Public Company Accounting Oversight Board (“PCAOB”), (ii
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
10 May 24
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
7:05am
30 years of experience in the biopharmaceutical industry with a focus on process development, manufacturing and facility oversight, and supply chain
8-K
EX-99.1
PROK
ProKidney Corp - Ordinary Shares
25 Mar 24
ProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations
4:07pm
. Ernst has over 30 years of experience in the biopharmaceutical industry with a focus on process development, manufacturing and facility oversight
8-K
EX-1.1
4tn13hg5h5pszw
19 Jan 24
Entry into a Material Definitive Agreement
4:19pm
DEF 14A
tqsenq
26 May 23
Definitive proxy
8:00am
424B3
0znx8j5v wd
21 Apr 23
Prospectus supplement
4:18pm
POS AM
rkuqxq u02n
17 Apr 23
Prospectus update (post-effective amendment)
5:01pm
424B3
3whsq5wh gxf7
9 Sep 22
Prospectus supplement
5:05pm
DEFM14A
5kue3i
10 Jun 22
Proxy related to merger
4:54pm
8-K/A
EX-99.1
v293e
10 Jun 22
Other Events
4:12pm
DEFA14A
j045mfn1
11 May 22
Additional proxy soliciting materials
4:55pm
PRER14A
ll09 5g1lh1xx
11 Apr 22
Preliminary revised proxy
5:29pm
10-K
2491kf2sj7ny01ctcq
23 Mar 22
Annual report
5:32pm